MedTrace Logo

A Microneurography (MNG) Study of VX-150 in Healthy Participants

NCT05418712 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2022-10-14

No results posted yet for this study

Summary

The purpose of this study is to determine if C fiber conduction is impacted by NAV1.8 modulation.

Conditions

Interventions

DRUG

Placebo

Placebo matched to VX-150 for oral administration.

DRUG

VX-150

Solution or Suspension for oral administration.

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-16
Primary Completion
2022-09-14
Completion
2022-09-23
FDA Drug
Yes

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05418712 on ClinicalTrials.gov